Page 28 - Testing Solutions News Today : Breaking News, Live Updates & Top Stories | Vimarsana

(0) RARITAN, N.J., April 13, 2021 /PRNewswire/ -- Ortho Clinical Diagnostics (Nasdaq: OCDX), one of the world's largest pure-play in vitro diagnostics companies, today announced it received CE Marking for its VITROS SARS-CoV-2 Antigen Test, initially launched in October 2020. The CE Mark allows for more convenient sample collection and expanded viral transport media. "Regions across the world are in various stages of reopening and recovering, yet there remains a great need for reliable tests that can be performed quickly and in bulk to ensure the continued safety of these 'back-to-normal' me...

Medical Testing Solutions  Medical Testing Solutions is the industry-leading medical gas service and equipment supplier. We offer medical gas services including, annual medical gas testing, medical gas certifications for construction, and preventative maintenance programs.

Share this article - The new contract will deliver Ortho with funding for capacity expansion to provide up to 6.7 million COVID-19 tests per month dedicated for the U.S. market over the next 12-14 months  RARITAN, N.J., March 31, 2021 /PRNewswire/ -- Ortho Clinical Diagnostics (Nasdaq: OCDX), one of the world's largest pure-play IVD companies, today announced that through its continued partnership with the Biomedical Advanced Research and Development Authority (BARDA) and the U.S. Department of Defense, the company been awarded an undefinitized contract which will lead to a $53.7 million co...

Share this article Share this article ROCKVILLE, Md., Feb. 1, 2021 /PRNewswire/ -- Since November of 2020, scientist and the medical community have been following three new variants of SARS-CoV-2 with great interest and concern. 1,2 The B.1.1.7 variant discovered in the United Kingdom, the South African and the Brazilian variants have all found their way to the United States and based on some reports, may be 50% more transmissible than the current strain of SARS-CoV-2. 3 Cellex qSARS-Cov-2 Antigen Rapid Test from Spartan Medical Inc. The Cellex qSARS-CoV-2 Antigen Rapid Test manufactured by ...

Share this article Share this article - Ortho's VITROS® SARS-CoV-2 Antigen Test is the first high-volume COVID-19 antigen test to receive Food and Drug Administration (FDA) Emergency Use Authorization (EUA). - With utility for mass-scale testing and same-day results for labs, Ortho's latest COVID-19 solution can run up to 130 tests per hour. - The test is run on Ortho's high-volume VITROS® Systems, which are installed in over 5,600 laboratories around the world with 1,500 installed in the U.S. RARITAN, N.J., Jan. 12, 2021 /PRNewswire/ -- Ortho Clinical Diagnostics, a global leader of in vi...